EVERTEC (EVTC) Competitors $35.79 -0.08 (-0.22%) (As of 02:28 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EVTC vs. HQY, LYFT, QXO, ETSY, MARA, NVEI, TNET, ALIT, DXC, and PAYOShould you be buying EVERTEC stock or one of its competitors? The main competitors of EVERTEC include HealthEquity (HQY), Lyft (LYFT), QXO (QXO), Etsy (ETSY), Marathon Digital (MARA), Nuvei (NVEI), TriNet Group (TNET), Alight (ALIT), DXC Technology (DXC), and Payoneer Global (PAYO). These companies are all part of the "business services" industry. EVERTEC vs. HealthEquity Lyft QXO Etsy Marathon Digital Nuvei TriNet Group Alight DXC Technology Payoneer Global HealthEquity (NASDAQ:HQY) and EVERTEC (NYSE:EVTC) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment. Does the media refer more to HQY or EVTC? In the previous week, HealthEquity had 3 more articles in the media than EVERTEC. MarketBeat recorded 12 mentions for HealthEquity and 9 mentions for EVERTEC. HealthEquity's average media sentiment score of 0.87 beat EVERTEC's score of 0.81 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EVERTEC 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, HQY or EVTC? EVERTEC has lower revenue, but higher earnings than HealthEquity. EVERTEC is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthEquity$999.59M8.76$55.71M$1.2083.56EVERTEC$694.71M3.30$79.72M$1.2828.02 Does the MarketBeat Community believe in HQY or EVTC? HealthEquity received 244 more outperform votes than EVERTEC when rated by MarketBeat users. Likewise, 69.89% of users gave HealthEquity an outperform vote while only 59.33% of users gave EVERTEC an outperform vote. CompanyUnderperformOutperformHealthEquityOutperform Votes52769.89% Underperform Votes22730.11% EVERTECOutperform Votes28359.33% Underperform Votes19440.67% Do institutionals & insiders hold more shares of HQY or EVTC? 99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 96.8% of EVERTEC shares are owned by institutional investors. 2.2% of HealthEquity shares are owned by insiders. Comparatively, 0.8% of EVERTEC shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is HQY or EVTC more profitable? EVERTEC has a net margin of 10.20% compared to HealthEquity's net margin of 9.61%. EVERTEC's return on equity of 33.01% beat HealthEquity's return on equity.Company Net Margins Return on Equity Return on Assets HealthEquity9.61% 9.01% 5.73% EVERTEC 10.20%33.01%8.85% Which has more volatility and risk, HQY or EVTC? HealthEquity has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, EVERTEC has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Do analysts rate HQY or EVTC? HealthEquity currently has a consensus price target of $103.83, indicating a potential upside of 3.55%. EVERTEC has a consensus price target of $34.33, indicating a potential downside of 4.28%. Given HealthEquity's stronger consensus rating and higher probable upside, research analysts plainly believe HealthEquity is more favorable than EVERTEC.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00EVERTEC 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67 SummaryHealthEquity beats EVERTEC on 12 of the 18 factors compared between the two stocks. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Get EVERTEC News Delivered to You Automatically Sign up to receive the latest news and ratings for EVTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVTC vs. The Competition Export to ExcelMetricEVERTECData processing & preparation IndustryBusiness SectorNYSE ExchangeMarket Cap$2.29B$4.31B$7.07B$20.17BDividend Yield0.57%2.99%2.47%3.47%P/E Ratio28.0235.1245.5445.12Price / Sales3.305.59223.5018.17Price / Cash8.6330.6727.2521.38Price / Book4.536.324.895.05Net Income$79.72M$39.38M$121.16M$988.74M7 Day Performance10.68%6.24%9.39%3.95%1 Month Performance8.17%12.17%8.71%3.63%1 Year Performance8.93%15.56%36.09%32.74% EVERTEC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVTCEVERTEC1.6921 of 5 stars$35.79-0.2%$34.33-4.1%+8.9%$2.29B$694.71M27.965,000Earnings ReportHQYHealthEquity3.6755 of 5 stars$97.20-0.8%N/A+45.3%$8.49B$999.59M81.003,150News CoveragePositive NewsLYFTLyft3.8697 of 5 stars$17.69+22.8%N/A+81.2%$7.26B$4.40B-110.562,945Earnings ReportAnalyst ForecastGap UpHigh Trading VolumeQXOQXO1.3444 of 5 stars$15.65+2.6%N/AN/A$6.24B$54.52M-1.27195Gap UpHigh Trading VolumeETSYEtsy4.3924 of 5 stars$53.41+0.6%N/A-14.6%$6.01B$2.75B27.252,420MARAMarathon Digital1.9911 of 5 stars$19.31-0.1%N/A+160.2%$5.69B$387.51M12.38109News CoverageGap DownNVEINuvei1.6207 of 5 stars$33.45+0.1%N/A+80.9%$4.74B$1.31B-371.632,202Short Interest ↑TNETTriNet Group4.3111 of 5 stars$93.18+0.1%N/A-11.7%$4.61B$4.92B17.953,600Positive NewsALITAlight3.2703 of 5 stars$7.47-0.9%N/A+8.3%$4.11B$3.41B-16.9718,000News CoverageGap UpDXCDXC Technology2.8205 of 5 stars$22.56+5.3%N/A+4.2%$4.08B$13.67B66.35130,000Earnings ReportAnalyst ForecastShort Interest ↓News CoveragePAYOPayoneer Global4.1828 of 5 stars$10.68+3.2%N/A+91.0%$3.95B$940.30M39.562,167Earnings Report Related Companies and Tools Related Companies HQY Competitors LYFT Competitors QXO Competitors ETSY Competitors MARA Competitors NVEI Competitors TNET Competitors ALIT Competitors DXC Competitors PAYO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EVTC) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredOptions Trading on Bitcoin?SEC Approves Crypto Options Trading Select altcoins poised for RAPID growth by early 2025… Crypto 101 Media | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EVERTEC, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EVERTEC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.